99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
Clinical trial NCT05622240 · UNKNOWN
Trial details
- NCT number
- NCT05622240
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2023-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.